Pengfei Zhang

3PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 09, 2026
CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial.

Ruihong Dai, Pengfei Zhang, Mo Cheng

|Feb 19, 2025
Cost-effectiveness analysis of daratumumab plus bortezomib, melphalan and prednisone versus bortezomib, melphalan and prednisone in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation.

Dan Xie, Peng-Fei Zhang

|Dec 04, 2024
Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial.

Peng-Fei Zhang, Wei-Han Zhang, Xi-Jiao Liu

Pageof 1

Frequent Collaborators

1 joint publications

Wei-Han Zhang

1 joint publications

Kun Yang

1 joint publications

Hong-Feng Gou

1 joint publications

Ruihong Dai